Advanced search×

Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment.

Am J Respir Crit Care Med 182(3):426-32 (2010) PMID 20413630 PMCID PMC2921603

Extensively drug-resistant (XDR) tuberculosis (TB) may arise in individuals on treatment for multidrug-resistant (MDR) TB. Preventing this amplification of resistance will likely improve clinical outcomes and delay the secondary spread of XDR-TB.

DOI: 10.1164/rccm.200911-1768OC
Version: za2963e q8zac q8zbf q8zc3 q8zd6 q8zee q8zff q8zgb

Similar articles you may find interesting…

  1. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study.

    Lancet 372(9647):1403-9 (2008) PMID 18723218

    Of 608 patients with multidrug resistant tuberculosis, 29 (4.8%) patients had baseline XDR tuberculosis. Treatment failure was more common in patients with XDR tuberculosis than in those with non-XDR tuberculosis (31%vs 8.5%, p=0.0008). 48.3% of patients with XDR tuberculosis and 66.7% of patients w...
  2. Targeting of adenosine receptors in ischemia-reperfusion injury.

    Expert Opin Ther Targets 15(1):103-18 (2011) PMID 21110787

    Importance of the field: Ischemia-reperfusion (IR) injury is a common problem after transplantation as well as myocardial infarction and stroke. IR initiates an inflammatory response leading to rapid tissue damage. Adenosine, produced in response to IR, is generally considered a protective signaling...
  3. Role of heme oxygenase-1 in transplantation.

    Transpl Int 23(11):1071-81 (2010) PMID 20819190

    We herein consistently summarize the huge amount of data on HO-1 and transplantation that have been generated in multiple laboratories during the last 15 years and suggest possible clinical implications and applications for the near future....